| Application number | Title of the application | Filing Date | Status |
|---|
| 10/070226 | Proteins associated with cell differentiation | Feb 26, 2002 | Abandoned |
Array
(
[id] => 6778565
[patent_doc_number] => 20030049646
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-13
[patent_title] => 'Protein that enhances expression of potassium channels on cell surfaces and nucleic acids that encode the same'
[patent_app_type] => new
[patent_app_number] => 10/075074
[patent_app_country] => US
[patent_app_date] => 2002-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 6942
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0049/20030049646.pdf
[firstpage_image] =>[orig_patent_app_number] => 10075074
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/075074 | Protein that enhances expression of potassium channels on cell surfaces and nucleic acids that encode the same | Feb 12, 2002 | Issued |
Array
(
[id] => 6797457
[patent_doc_number] => 20030176331
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-18
[patent_title] => 'Modified proteins, designer toxins, and methods of making thereof'
[patent_app_type] => new
[patent_app_number] => 10/074596
[patent_app_country] => US
[patent_app_date] => 2002-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 52391
[patent_no_of_claims] => 88
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20030176331.pdf
[firstpage_image] =>[orig_patent_app_number] => 10074596
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/074596 | Modified proteins, designer toxins, and methods of making thereof | Feb 11, 2002 | Issued |
Array
(
[id] => 956146
[patent_doc_number] => 06955896
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-10-18
[patent_title] => 'Alzheimer\'s related proteins and methods of use'
[patent_app_type] => utility
[patent_app_number] => 10/071900
[patent_app_country] => US
[patent_app_date] => 2002-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 9485
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 126
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/955/06955896.pdf
[firstpage_image] =>[orig_patent_app_number] => 10071900
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/071900 | Alzheimer's related proteins and methods of use | Feb 7, 2002 | Issued |
Array
(
[id] => 7678990
[patent_doc_number] => 20030195346
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-16
[patent_title] => 'Secreted protein HEMCM42'
[patent_app_type] => new
[patent_app_number] => 10/062599
[patent_app_country] => US
[patent_app_date] => 2002-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 56378
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0195/20030195346.pdf
[firstpage_image] =>[orig_patent_app_number] => 10062599
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/062599 | Secreted protein HEMCM42 | Feb 4, 2002 | Abandoned |
Array
(
[id] => 6801085
[patent_doc_number] => 20030096250
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-22
[patent_title] => 'Homologous 28-kilodalton immunodominant protein genes of Ehrlichia canis and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/062920
[patent_app_country] => US
[patent_app_date] => 2002-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 12461
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0096/20030096250.pdf
[firstpage_image] =>[orig_patent_app_number] => 10062920
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/062920 | Homologous 28-kilodalton immunodominant protein genes of Ehrlichia canis and uses thereof | Jan 30, 2002 | Issued |
| 10/031915 | Cell cycle and proliferation proteins | Jan 17, 2002 | Abandoned |
| 09/830980 | Regulator of notch signaling activity | Jan 13, 2002 | Abandoned |
| 10/432687 | Human lim domain proteins | Jan 9, 2002 | Abandoned |
Array
(
[id] => 6829890
[patent_doc_number] => 20030180948
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-25
[patent_title] => 'Superficial zone protein and methods of making and using same'
[patent_app_type] => new
[patent_app_number] => 10/038694
[patent_app_country] => US
[patent_app_date] => 2001-12-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 21969
[patent_no_of_claims] => 80
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0180/20030180948.pdf
[firstpage_image] =>[orig_patent_app_number] => 10038694
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/038694 | Superficial zone protein and methods of making and using same | Dec 30, 2001 | Abandoned |
Array
(
[id] => 6715952
[patent_doc_number] => 20030027300
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-02-06
[patent_title] => 'Human hairless gene and protein'
[patent_app_type] => new
[patent_app_number] => 10/024368
[patent_app_country] => US
[patent_app_date] => 2001-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 17444
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0027/20030027300.pdf
[firstpage_image] =>[orig_patent_app_number] => 10024368
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/024368 | Human hairless gene and protein | Dec 20, 2001 | Issued |
Array
(
[id] => 975592
[patent_doc_number] => 06933273
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-08-23
[patent_title] => 'Isolated laminin 10'
[patent_app_type] => utility
[patent_app_number] => 10/037182
[patent_app_country] => US
[patent_app_date] => 2001-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 10
[patent_no_of_words] => 15116
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/933/06933273.pdf
[firstpage_image] =>[orig_patent_app_number] => 10037182
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/037182 | Isolated laminin 10 | Dec 20, 2001 | Issued |
Array
(
[id] => 7314241
[patent_doc_number] => 20040033971
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-19
[patent_title] => 'Polypeptides and nucleic acids encoding same'
[patent_app_type] => new
[patent_app_number] => 10/029020
[patent_app_country] => US
[patent_app_date] => 2001-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 103924
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0033/20040033971.pdf
[firstpage_image] =>[orig_patent_app_number] => 10029020
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/029020 | Polypeptides and nucleic acids encoding same | Dec 18, 2001 | Abandoned |
Array
(
[id] => 634009
[patent_doc_number] => 07129065
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-10-31
[patent_title] => 'bHLH-PAS proteins, genes thereof and utilization of the same'
[patent_app_type] => utility
[patent_app_number] => 10/465920
[patent_app_country] => US
[patent_app_date] => 2001-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 27882
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/129/07129065.pdf
[firstpage_image] =>[orig_patent_app_number] => 10465920
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/465920 | bHLH-PAS proteins, genes thereof and utilization of the same | Dec 16, 2001 | Issued |
| 10/009328 | Human transport proteins | Dec 3, 2001 | Abandoned |
Array
(
[id] => 6274684
[patent_doc_number] => 20020106361
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-08
[patent_title] => 'Composition'
[patent_app_type] => new
[patent_app_number] => 09/998284
[patent_app_country] => US
[patent_app_date] => 2001-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8816
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0106/20020106361.pdf
[firstpage_image] =>[orig_patent_app_number] => 09998284
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/998284 | Composition | Nov 29, 2001 | Abandoned |
Array
(
[id] => 5987335
[patent_doc_number] => 20020099016
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-07-25
[patent_title] => 'Antisecretory factor peptides regulating pathological permeability changes'
[patent_app_type] => new
[patent_app_number] => 09/991792
[patent_app_country] => US
[patent_app_date] => 2001-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 8611
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0099/20020099016.pdf
[firstpage_image] =>[orig_patent_app_number] => 09991792
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/991792 | Antisecretory factor peptides regulating pathological permeability changes | Nov 25, 2001 | Abandoned |
Array
(
[id] => 6648041
[patent_doc_number] => 20030104526
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-05
[patent_title] => 'Position dependent recognition of GNN nucleotide triplets by zinc fingers'
[patent_app_type] => new
[patent_app_number] => 09/989994
[patent_app_country] => US
[patent_app_date] => 2001-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 24683
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 534
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0104/20030104526.pdf
[firstpage_image] =>[orig_patent_app_number] => 09989994
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/989994 | Position dependent recognition of GNN nucleotide triplets by zinc fingers | Nov 19, 2001 | Abandoned |
Array
(
[id] => 5908012
[patent_doc_number] => 20020142962
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-03
[patent_title] => 'Inhibition of abnormal cell growth with corticotropin-releasing hormone analogs'
[patent_app_type] => new
[patent_app_number] => 09/997498
[patent_app_country] => US
[patent_app_date] => 2001-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6031
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20020142962.pdf
[firstpage_image] =>[orig_patent_app_number] => 09997498
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/997498 | Inhibition of abnormal cell growth with corticotropin-releasing hormone analogs | Nov 18, 2001 | Issued |
Array
(
[id] => 1105621
[patent_doc_number] => 06812328
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-11-02
[patent_title] => 'Low oxygen affinity mutant hemoglobins'
[patent_app_type] => B2
[patent_app_number] => 09/986666
[patent_app_country] => US
[patent_app_date] => 2001-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 0
[patent_no_of_words] => 14040
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/812/06812328.pdf
[firstpage_image] =>[orig_patent_app_number] => 09986666
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/986666 | Low oxygen affinity mutant hemoglobins | Nov 8, 2001 | Issued |
